Peter Atadja, Ph.D.
Board Member
Traws Pharma, Inc. (TRAW)Equibles does not estimate personal net worth.
About Peter Atadja, Ph.D.
Peter Atadja, Ph.D. is recorded as Board Member at Traws Pharma, Inc. (TRAW) since December 15, 2022. Traws Pharma, Inc. reported in an 8-K filed December 19, 2022 that Peter Atadja, Ph.D. was appointed member of the Board, effective December 15, 2022. Traws Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Traws Pharma, Inc. includes Iain D. Dukes (CEO and Board Member), Iain Dukes (CEO and Board Member), Werner Cautreels (CEO and Board Member) and 7 others.
“On December 15, 2022 the Board of Directors (the “Board”) of Onconova Therapeutics, Inc. (the “Company”) increased the size of the Board to eight members and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Peter Atadja, Ph.D. and Trafford Clarke, Ph.D. as members of the Board, effective immediately.”
Affiliation history
-
Current
2022-12-15–present
Company network
Leadership on record at Traws Pharma, Inc.
- Iain D. Dukes CEO, Board Member
- Iain Dukes CEO, Board Member
- Werner Cautreels CEO, Board Member
- Jack E. Stover Chairman
- Jack Stover Chairman
- James J. Marino, JD, MBA Chairman
- Charles Parker CFO
- Nora Brennan CFO
- Nikolay Savchuk COO, Board Member
- Iain Dukes, D.Phil. Board Member